Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

BACKGROUND: Artemisinin resistance observed in Southeast Asia threatens the continued use of artemisinin-based combination therapy in endemic countries. Additionally, the diversity of chemical mode of action in the global portfolio of marketed antimalarials is extremely limited. Addressing the urgen...

全面介紹

書目詳細資料
Main Authors: Le Bihan, A, de Kanter, R, Angulo-Barturen, I, Binkert, C, Boss, C, Brun, R, Brunner, R, Buchmann, S, Burrows, J, Dechering, K, Delves, M, Ewerling, S, Ferrer, S, Fischli, C, Gamo-Benito, F, Gnädig, N, Heidmann, B, Jiménez-Díaz, M, Leroy, D, Martínez, M, Meyer, S, Moehrle, J, Ng, C, Noviyanti, R, Ruecker, A, Sanz, L, Sauerwein, R, Scheurer, C, Schleiferboeck, S, Sinden, R, Snyder, C, Straimer, J, Wirjanata, G, Marfurt, J, Price, R, Weller, T, Fischli, W, Fidock, D, Clozel, M, Wittlin, S
格式: Journal article
語言:English
出版: Public Library of Science 2016

相似書籍